Helios Biotechnology JSC (HOSE:HSL)

Vietnam · Delayed Price · Currency is VND

7,200.00

-100.00 (-1.37%)

At close: Nov 4, 2026

Helios Biotechnology JSC Financials Overview

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017
Revenue	1,985	45,939	139,246	389,734	221,883	167,112
Revenue Growth	-96.55%	-67.01%	-64.27%	75.65%	32.78%	-
Gross Profit	-740.38	1,318	11,179	18,559	24,723	18,539
Operating Income	-6,473	-3,157	6,660	13,803	23,403	17,747
Net Income	-3,055	15.61	6,758	11,755	23,679	17,526
Earnings Per Share	-71.52	0.40	175.00	295.10	1150.38	1877.37
EPS Growth	-	-99.77%	-40.70%	-74.35%	-38.72%	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Manufacturing Sector	3,781	87,895
Other Sectors	4,278	10,008
Commerce Sector	37,880	41,342
Total	45,939	139,246

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017
Cash & Investments	54,510	155,707	140,830	63,844	27,915	21,649
Total Debt	5,582	3,586	10,219	11,528	-	-
Net Cash (Debt)	48,927	152,121	130,611	52,316	27,915	21,649
Net Cash Growth	-51.56%	16.47%	149.66%	87.41%	28.94%	-
Net Cash Per Share	1145.21	3944.28	3386.58	1313.41	1356.17	2319.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017
Operating Cash Flow	60,785	-23,987	42,799	398.28	7,112	-38,365
Capital Expenditures	-52,913	-25,088	-1,237	-1,598	-1,010	-286.45
Free Cash Flow	7,873	-49,074	41,562	-1,200	6,102	-38,652
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017
Gross Margin	-37.29%	2.87%	8.03%	4.76%	11.14%	11.09%
Operating Margin	-326.02%	-6.87%	4.78%	3.54%	10.55%	10.62%
Pretax Margin	-127.67%	12.29%	5.30%	3.33%	10.67%	10.49%
Profit Margin	-153.90%	0.03%	4.85%	3.02%	10.67%	10.49%
FCF Margin	396.54%	-106.83%	29.85%	-0.31%	2.75%	-23.13%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '17 Dec 31, 2017	Jan '17 Jan 1, 2017
PE Ratio	-	17267.89	23.23	30.40	-	-
P/FCF Ratio	35.27	-	3.78	-	-	-
PS Ratio	139.87	5.87	1.13	0.92	-	-